Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $700M bought by 129 insiders at 88 companies
- $1.3B sold by 80 insiders outside a trading plan
- $1B sold by 336 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$247M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.4M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$66.3M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$62M
-
GMEGameStop CorporationRyan CohenCEO$17.1M
-
AVRAnteris Technologies Global Corp.L1 Capital Pty Ltd10% owner$9.7M
-
BORRBorr Drilling LimitedTor Olav TroimDirector$6.2M
-
PAMPampa Energia S.A.Damian Miguel MindlinVicepresident$5.6M
-
GPUSHyperscale Data, Inc.Milton C Ault IIIChair · +1 joint filer$5.1M
Biggest sales
Past week · by insider, all their filings added up · planned sales marked
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
THTarget Hospitality Corp.TDR Capital II Investments LP10% owner · +9 joint filers$202M
-
ESTCElastic N.V.Steven SchuurmanDirector$135M
-
NBISNebius Group N.V.Ophir NaveCOO$118M
-
CBRSCerebras Systems Inc.Dhiraj MallickCOO$80.8M
-
CRWDCrowdStrike Holdings, Inc.Michael SentonasPresident$64.2M
-
AAPLApple Inc ComTimothy D CookChair$63.8M
-
MPWRMonolithic Power Systems, Inc.Michael HsingCEO$40.3M
-
ACTEnact Holdings, Inc.Genworth Holdings, Inc.10% owner$37.1M
-
WDAYWorkday, Inc.David A Duffield10% owner$37.1M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Susan Butenhoff DirectorOOMAOoma, Inc.Sale$198K 9,000 shares at $22.03 7.6% of stakeTraded Sep 22 Filed Sep 24
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$5.1M 20,000 shares at $253.17 0.3% of stakeTraded Sep 22–23 Filed Sep 24
-
Jessica Newcomb Principal Accounting OfficerTNGXTango Therapeutics, Inc.Planned sale$199K 8,200 shares at $24.22 12% of stakeTraded Sep 22 Filed Sep 24
-
Robert P Rozek CFOKFYKorn FerrySale$278K 3,709 shares at $75.03 2.3% of stakeTraded Sep 23 Filed Sep 24
-
Dss, Inc. 10% ownerIBOImpact BioMedical, Inc.Sale$1,686 906 shares at $1.86 0.2% of stakeTraded Sep 22–24 Filed Sep 24
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$26.7M 307,692 shares at $86.82Traded Sep 22 Filed Sep 24
-
Nitin Agrawal CFOCRWVCoreWeave, Inc.Planned sale$4.8M 55,764 shares at $86.83 30% of stakeTraded Sep 22 Filed Sep 24
-
Jennifer Newstead SVP, GC and Government AffairsAAPLApple Inc ComPlanned sale$816K 2,399 shares at $340.06 5.1% of stakeTraded Sep 22 Filed Sep 24
-
Elizabeth M Anderson DirectorRVMDRevolution Medicines, Inc.Planned sale$2M 10,143 shares at $193.04 70% of stakeTraded Sep 22 Filed Sep 24
-
Benoit Dageville DirectorSNOWSnowflake Inc.Planned sale$17M 50,000 shares at $339.08 2% of stakeTraded Sep 23 Filed Sep 24
-
Jonathan Mead Beaulier Chief Revenue OfficerSNOWSnowflake Inc.Sale$254K 755 shares at $336.36 0.4% of stakeTraded Sep 23 Filed Sep 24
-
Joseph Devivo CEOBFLYButterfly Network, Inc.Planned sale$60K 5,980 shares at $10.01 0.1% of stakeTraded Sep 22–23 Filed Sep 24
-
James R. Kasinger General Counsel and SecretaryCRSPCRISPR Therapeutics AGPlanned sale$626K 10,400 shares at $60.24 9.9% of stakeTraded Sep 22 Filed Sep 24
-
Todd C Cooper PresidentCLSCelestica, Inc.Planned sale$7.2M 20,118 shares at $360.00 22% of stakeTraded Sep 23 Filed Sep 24
-
Robert Mionis CEOCLSCelestica, Inc.Planned sale$8.5M 23,396 shares at $364.22 100% of stakeTraded Sep 23 Filed Sep 24
-
ISQ Global Fund II GP LLC 10% owner · +4 joint filersKNTKKinetik Holdings Inc.Sale$3.4M 64,131 shares at $53.66 14% of stakeTraded Sep 22–23 Filed Sep 24
-
Timothy William Miller Vice President, SalesGIFTGiftify, Inc.Planned sale$1,000 1,000 shares at $1.00 2.5% of stakeTraded May 3 Filed Sep 24
-
Diane M Gershowitz DirectorMCSMarcus Corporation (The)Sale$1.4M 50,000 shares at $27.61 29% of stakeTraded Sep 23 Filed Sep 24
-
Todd McKinnon CEOOKTAOkta, Inc.Planned sale$9.4M 48,822 shares at $193.48 100% of stakeTraded Sep 22 Filed Sep 24
-
Salvatore Privitera Chief Technical OfficerATRCAtriCure, Inc.Planned sale$271K 4,519 shares at $60.00 3.1% of stakeTraded Sep 23 Filed Sep 24
-
Richard L Hardgrove DirectorSBFGSB Financial Group, Inc.Sale$108K 3,702 shares at $29.08 26% of stakeTraded Sep 15 Filed Sep 24
-
Darren S Raiguel COOPLUSePlus inc.Planned sale$93 1 share at $93.44 <0.1% of stakeTraded Sep 22 Filed Sep 24
-
Vladimir Tenev CEOHOODRobinhood Markets, Inc.Planned sale$30.2M 240,834 shares at $125.33 100% of stakeTraded Sep 22 Filed Sep 24
-
Andrew J. Schwab DirectorSKYESkye Bioscience, Inc.Sale$240K 148,079 shares at $1.62 100% of stakeTraded Sep 22–23 Filed Sep 24
-
Martine A Rothblatt CEOUTHRUnited Therapeutics CorporationPlanned sale$4.7M 9,500 shares at $491.57 2.8% of stakeTraded Sep 23 Filed Sep 24
-
Shehnaaz Suliman DirectorTXG10x Genomics, Inc.Planned sale$465K 5,723 shares at $81.19 19% of stakeTraded Sep 22 Filed Sep 24
-
Jessica L. Thomas Chief Accounting OfficerSLNHSoluna Holdings, Inc.Sale$38K 30,000 shares at $1.26 2% of stakeTraded Sep 23 Filed Sep 24
-
Serge Saxonov CEOTXG10x Genomics, Inc.Planned sale$2M 25,000 shares at $81.22 2.3% of stakeTraded Sep 22 Filed Sep 24
-
James W Wert DirectorPKOHPark-Ohio Holdings Corp.Sale$143K 3,000 shares at $47.50 3.4% of stakeTraded Sep 24 Filed Sep 24
-
Ugur Sahin CEOBNTXBioNTech SEPlanned sale$6.8M 69,000 shares at $99.17 17% of stakeTraded Sep 23–24 Filed Sep 24
-
Kathleen Scarlett Sevp, CHROBBYBest Buy Co., Inc.Sale$10.7M 116,062 shares at $92.15 50% of stakeTraded Sep 23 Filed Sep 24
-
Gary Bowman CEOBWMNBowman Consulting Group Ltd.Planned sale$2.6M 60,000 shares at $42.55Traded Sep 23 Filed Sep 24
-
John Colgrove Chief Visionary OfficerPEverpure, Inc.Planned sale$22.7M 200,000 shares at $113.26 100% of stakeTraded Sep 22–24 Filed Sep 24
-
Henry Nance COOBOXLBoxlight CorporationSale$5 1 share at $5.47 0.5% of stakeTraded Aug 25 Filed Sep 24
-
Michael Lane Executive Vice PresidentSEICSEI Investments CompanySale$247K 2,400 shares at $102.78 5.7% of stakeTraded Sep 22 Filed Sep 24
-
Eric P Lefkofsky CEOTEMTempus AI, Inc.Planned sale$19.4M 250,000 shares at $77.47 71% of stakeTraded Sep 22 Filed Sep 24
-
Gwynne Shotwell COOSPCXSpace Exploration Technologies (SpaceX)Planned sale$52.5M 342,170 shares at $153.57 12% of stakeTraded Sep 22 Filed Sep 24
-
Christopher Hite ChairRPRXRoyalty Pharma plcPlanned sale$5.9M 100,000 shares at $58.53 27% of stakeTraded Sep 22 Filed Sep 24
-
Jonathan Shar CEOBNEDBarnes & Noble Education, IncSale$331K 30,000 shares at $11.04 8.4% of stakeTraded Sep 22 Filed Sep 24
-
Lynn Vojvodich Radakovich DirectorDELLDell Technologies Inc.Planned sale$1.1M 2,022 shares at $565.28 7.4% of stakeTraded Sep 22 Filed Sep 24
-
Abraham Ceesay CEORAPPRapport Therapeutics, Inc.Planned sale$87K 2,210 shares at $39.17 0.5% of stakeTraded Sep 23 Filed Sep 24
-
Japan Post Holdings Co., Ltd. 10% ownerAFLAflac IncorporatedPlanned sale$1.4M 12,200 shares at $114.55 <0.1% of stakeTraded Sep 22 Filed Sep 24
-
Akos Czibere Chief Medical OfficerAKTSAktis Oncology, Inc.Planned sale$259K 12,500 shares at $20.69 100% of stakeTraded Sep 23 Filed Sep 24
-
Michael Kiernan Chief Revenue OfficerNXDRNextdoor Holdings, Inc.Planned sale$127K 50,000 shares at $2.54 9.8% of stakeTraded Sep 22 Filed Sep 24
-
Morgan Fong Chief Legal OfficerCARTMaplebear Inc.Planned sale$827K 18,390 shares at $44.98 3.4% of stakeTraded Sep 22 Filed Sep 24
-
Wanjiku Juanita Walcott Chief Legal & Bus Affairs Ofc.PINSPinterest, Inc.Planned sale$257K 14,103 shares at $18.21 2.1% of stakeTraded Sep 23 Filed Sep 24
-
Jeremy Skule EVP, CsoNDAQNasdaq, Inc.Planned sale$107K 1,125 shares at $95.00 1.1% of stakeTraded Sep 22 Filed Sep 24
-
Ofer Koren CFOGLBEGlobal-E Online Ltd.Planned sale$2.1M 50,000 shares at $41.23 25% of stakeTraded Sep 22 Filed Sep 24
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.